The North America Transplant market is projected to grow at a CAGR of 3.29% to reach a market size of US$50.237 billion by 2024, from US$ 41.375 billion in 2018. Transplants are also known as grafts or organ transplants where a section of a tissue or a complete organ from its original site is transferred to the area of interest in an individual (same or separate). Thus, the transplanted organ or graft continue to receive nourishment from the new and healthy environment. Prevalence of chronic diseases is one of the major factors driving the growth of the North America transplant market in the forecast period. Furthermore, growing health awareness along with government initiatives regarding organ donation is driving the market growth. However, the shortage of organ donors and incidences of transplant rejection may impede the growth of the North America Transplant market during the forecast period. Additionally, technological advancements will drive market growth in the forecast period and in the upcoming years.
The “North America Transplant Market – Forecasts from 2019 to 2024” is an exhaustive study which aims to present the key market trends through various chapters focusing on different aspects of the market. The study provides a detailed market overview through the market dynamics sections which detail key market, drivers, restraints, and opportunities in the current market. The report analyzes key opportunity regional markets, and the current technology penetration through lifecycle analysis. The report also analyzes the market through comprehensive market segmentation by type, procedure, product, and country.
The North America Transplant market on segmented based on type, procedure, product, and country. Based on type the market has been segmented into tissue transplant and organ transplant. Organ transplant is further segmented into living donors and deceased donors. By procedure, the market has been segmented into autotransplantation, allotransplantation, and xenotransplantation. By product, the market has been classified into immunosuppressive drugs, preservation solutions, and organ transport systems.
Country-wise analysis has been provided with detailed analysis and forecast for the period 2018 to 2024, taking 2018 as the base year. The regional market has been broken down into USA, Canada, and Mexico analyzing 3 major countries across the North American region with thorough analysis and forecast along with prevailing market trends and opportunities which each of these countries present for the manufacturers.
Major players in the North America transplant market have been covered along with their relative competitive position and strategies. The report also mentions recent deals and investments of different market players over the last year. The company profiles section details the business overview, financial performance for the past three years, key products and services being offered along with the recent developments of these important players in the North America transplant market.
The North America Transplant market has been analyzed through following segments:
Organ Transport Systems
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.6. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Secondary Sources
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1. Market Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5. Porter’s Five Force Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Life Cycle Analysis - Regional Snapshot
4.7. Market Attractiveness
5. NORTH AMERICA TRANSPLANT MARKET BY TYPE
5.1. Tissue Transplant
5.2. Organ Transplant
5.2.1. Living Donors
5.2.2. Deceased Donors
6. NORTH AMERICA TRANSPLANT MARKET BY PROCEDURE
7. NORTH AMERICA TRANSPLANT MARKET BY PRODUCT
7.1. Immunosuppresive drugs
7.2. Preservation Solutions
7.3. Organ Transport Systems
8. NORTH AMERICA TRANSPLANT MARKET BY COUNTRY
9. COMPETITIVE INTELLIGENCE
9.1. Competitive Benchmarking and Analysis
9.2. Recent Investment and Deals
9.3. Strategies of Key Players
10. COMPANY PROFILES
10.1. Veloxis Pharmaceuticals, Inc.
10.2. Bridge to Life Ltd.
10.3. Paragonix Technologies Inc.
10.4. Global Transplant Solutions
10.5. XVIVO Perfusion
10.7. Novartis Pharmaceuticals Corporation
10.8 TransMedics, Inc.
LIST OF FIGURES
LIST OF TABLES
Veloxis Pharmaceuticals, Inc.
Bridge to Life Ltd.
Paragonix Technologies Inc.
Global Transplant Solutions
Novartis Pharmaceuticals Corporation
All our studies come with 2 months of analyst support.
We are in compliance with the global privacy laws.